merck glp-1 drug Novo's Wegovy becomes first approved for MASH Are GLP-1 drugs for everyone?
Description
It is not DKA, but it is a signal to check ketones more frequently during periods of reduced appetite or GI side effects, not just when your glucose is high
Obes Rev (2020) 21(10):e13046
It is essential that people are involved in treatment decisions as this can influence how likely they are to continue taking a medication, which can, in turn, affect treatment success
10.1016/j.neubiorev.2003.11.010 39 LautarS
Jacques C, Floris I, Lejeune B
